ym 511 has been researched along with Breast Neoplasms in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Potter, BV; Thomas, MP | 1 |
| Gutti, G; Makar, S; Saha, T; Singh, SK; Swetha, R | 1 |
| Fujikura, T; Ideyama, Y; Kudoh, M; Mori, M; Nanya, T; Shikama, H; Susaki, Y | 1 |
1 review(s) available for ym 511 and Breast Neoplasms
| Article | Year |
|---|---|
Estrogen signaling: An emanating therapeutic target for breast cancer treatment.
Topics: Aromatase Inhibitors; Breast Neoplasms; Cell Line, Tumor; Estrogen Antagonists; Estrogens; Female; Humans; Ligands; Men; Molecular Structure; Receptors, Estrogen; Selective Estrogen Receptor Modulators; Signal Transduction; Sulfatases | 2019 |
2 other study(ies) available for ym 511 and Breast Neoplasms
| Article | Year |
|---|---|
Discovery and Development of the Aryl O-Sulfamate Pharmacophore for Oncology and Women's Health.
Topics: Animals; Antineoplastic Agents; Aromatase Inhibitors; Breast Neoplasms; Drug Discovery; Endometriosis; Estrone; Female; Humans; Male; Molecular Targeted Therapy; Prostatic Neoplasms; Steryl-Sulfatase; Sulfonic Acids; Tubulin Modulators | 2015 |
Inhibitory effect of a novel non-steroidal aromatase inhibitor, YM511 on the proliferation of MCF-7 human breast cancer cell.
Topics: Adenocarcinoma; Aromatase Inhibitors; Breast Neoplasms; Cell Division; DNA; Enzyme Inhibitors; Estradiol; Fadrozole; Fluorouracil; Humans; Luciferases; Plasmids; Receptors, Estrogen; Testosterone; Transcription, Genetic; Transfection; Triazoles; Tumor Cells, Cultured | 1996 |